Heather Ribaudo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Heather ribaudo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Heather Ribaudo Today - Breaking & Trending Today

Daily statin reduces the risk of cardiovascular disease in people living with HIV, large NIH study finds

A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population. A planned interim analysis of data from theA National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population. A planned interim analysis of data from the ยป The FINANCIAL Health&Beauty ....

United States , Harvard University , Heather Ribaudo , Steven Grinspoon , Pamela Douglas , Garyh Gibbons , Hugh Auchincloss , Michaelt Lu , Clinical Coordinating Center , Kowa Pharmaceuticals America Inc , Blood Institute , Gilead Sciences Inc , Ursula Geller Professor Of Research , Data Coordinating Center , Duke University Department Of Medicine , Hospital Cardiovascular Imaging Research Center , Clinical Trials Group , A National Institutes Of Health , National Heart , National Institute Of Allergy , Department Of Biostatistics At Harvard University , Neat Id Foundation , National Institutes , Randomized Trial , Prevent Vascular Events , Data Safety ,

New insights about COVID-19 vaccination rates among people living with HIV

The AIDS Clinical Trials Group, the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that insights around COVID-19 vaccination rates among people living with HV have been published in the Journal of Infectious Diseases. ....

United States , South Africa , Puerto Rico , Harvard School Of Public Health , Judith Currier , Michael Lu , Evelynnes Fulda , Steven Grinspoon , Emily Henderson , Los Angeles , Pamela Douglas , Heather Ribaudo , University Of California , Gilead Sciences , National Institutes Of Health , National Institute Of Allergy , Clinical Trials Group , Harvard Medical School , Duke University , Blood Institute , National Heart , Pharmaceuticals America , Trials Group , Randomized Trial , Prevent Vascular Events , National Institute ,